Top Stocks for 2026 with Steven Cress. Join Premium and register now* »

Pfizer: Adjusted EPS Masks How Bad 2026 Really Looks

Pfizer faces another year of revenue decline in 2026, as Covid and loss-of-exclusivity headwinds weigh on top line growth, despite management's guidan...

FEATURED

Join our Top Stocks event on January 6, 2026

Steven Cress will explore Seeking Alpha’s Top 10 Stock Picks for 2026. Subscribe to Premium for $4.95 for your first month* and gain actionable insights for the year ahead.

All event participants must comply with Seeking Alpha’s Events Policy.

*Introductory offer for new subscribers only. $4.95 is charged for a 1-month paid trial to Premium. After 1 month, $299 charged for annual subscription. Auto-renews annually.